GeneDx Holdings Corp
WGS116.970USD
+4.480+3.98%
收盤 04/29, 16:00（美東）報價延遲15分鐘
3.28B總市值
虧損本益比TTM
關於 GeneDx Holdings Corp 公司
GeneDx Holdings Corp. 是一家基因組學公司。該公司專注於提供個性化和可操作的健康見解，以指導診斷、指導治療和改善藥物發現。該公司的部門包括 GeneDx，包括 Legacy GeneDx 和 Legacy Sema4。GeneDx 部門主要提供兒科和罕見疾病診斷，重點是全外顯子組和基因組測序，以及在較小程度上提供數據和信息服務。GeneDx 利用集成的實驗室流程、軟件工具和信息學功能組合來處理含脫氧核糖核酸 (DNA) 的樣本，分析有關患者特定遺傳變異的信息併爲臨牀醫生及其患者生成測試報告。GeneDx 提供各種基因診斷測試、篩查解決方案和信息。Legacy Sema4 診斷部門提供生殖和女性健康以及軀體腫瘤診斷測試和篩查產品。
公司簡介
公司代碼WGS
公司名稱GeneDx Holdings Corp
上市日期Sep 04, 2020
成立日期2020
CEOMs. Katherine A. Stueland
員工數量1000
證券類型Ordinary Share
年結日Sep 04
公司地址333 Ludlow Street
城市STAMFORD
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編06902
電話18887291206
網址https://sema4.com/
公司代碼WGS
上市日期Sep 04, 2020
成立日期2020
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
211.06K
+2.83%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
8.35K
+230.90%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
7.21K
+423.24%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
1.23K
-92.09%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
211.06K
+2.83%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
8.35K
+230.90%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
7.21K
+423.24%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
1.23K
-92.09%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Patients with third party insurance
234.70M
76.84%
Institutional customers
65.11M
21.32%
Other
3.29M
1.08%
Self pay patients
2.34M
0.77%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Patients with third party insurance
234.70M
76.84%
Institutional customers
65.11M
21.32%
Other
3.29M
1.08%
Self pay patients
2.34M
0.77%
股東統計
更新時間: 2月23日 週日
更新時間: 2月23日 週日
持股股東
股東類型
持股股東
股東統計
佔比
Casdin Capital, LLC
12.29%
Corvex Management LP
8.67%
Summit Partners Public Asset Management, LLC
5.00%
Icahn School of Medicine at Mount Sinai
4.81%
OPKO Health Inc
4.80%
Other
64.42%
持股股東
股東統計
佔比
Casdin Capital, LLC
12.29%
Corvex Management LP
8.67%
Summit Partners Public Asset Management, LLC
5.00%
Icahn School of Medicine at Mount Sinai
4.81%
OPKO Health Inc
4.80%
Other
64.42%
股東類型
股東統計
佔比
Hedge Fund
34.25%
Investment Advisor/Hedge Fund
24.66%
Investment Advisor
19.91%
Corporation
10.79%
Research Firm
5.54%
Pension Fund
1.72%
Individual Investor
1.71%
Bank and Trust
0.32%
Sovereign Wealth Fund
0.24%
Other
0.85%
機構持股
更新時間: 3月4日 週二
更新時間: 3月4日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
342
28.65M
102.06%
+563.46K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
2023Q1
296
21.58M
684.27%
+3.47M
2022Q4
305
9.98M
86.27%
+851.42K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Casdin Capital, LLC
3.51M
12.5%
--
--
Dec 31, 2024
Corvex Management LP
2.47M
8.81%
--
--
Dec 31, 2024
Summit Partners Public Asset Management, LLC
1.43M
5.08%
+671.40K
+88.86%
Feb 05, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.89%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.88%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.08M
3.85%
+90.95K
+9.20%
Dec 31, 2024
Goldman Sachs & Company, Inc.
1.06M
3.79%
+34.15K
+3.32%
Dec 31, 2024
Oracle Investment Management, Inc.
1.02M
3.65%
-22.30K
-2.13%
Dec 31, 2024
The Vanguard Group, Inc.
1.00M
3.58%
+156.77K
+18.51%
Dec 31, 2024
William Blair Investment Management, LLC
670.00K
2.39%
+508.67K
+315.31%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
Innovator IBD 50 Fund ETF
2.09%
SPDR S&P Health Care Services ETF
1.92%
Hypatia Women CEO ETF
0.62%
First Trust Active Factor Small Cap ETF
0.48%
Even Herd Long Short ETF
0.41%
iShares U.S. Healthcare Providers ETF
0.28%
iShares Micro-Cap ETF
0.24%
Principal U.S. Small-Cap ETF
0.23%
Vanguard US Momentum Factor ETF
0.18%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.15%
查看更多
Innovator IBD 50 Fund ETF
佔比2.09%
SPDR S&P Health Care Services ETF
佔比1.92%
Hypatia Women CEO ETF
佔比0.62%
First Trust Active Factor Small Cap ETF
佔比0.48%
Even Herd Long Short ETF
佔比0.41%
iShares U.S. Healthcare Providers ETF
佔比0.28%
iShares Micro-Cap ETF
佔比0.24%
Principal U.S. Small-Cap ETF
佔比0.23%
Vanguard US Momentum Factor ETF
佔比0.18%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.15%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
公告日期
類型
比率
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1